IMDX
Insight Molecular Diagnostics
IMDX
IMDX
26 hedge funds and large institutions have $21.8M invested in Insight Molecular Diagnostics in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
21% less funds holding
Funds holding: 33 → 26 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$74K | |
| 2 | +$60K | |
| 3 | +$46.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$11.6K |
Top Sellers
| 1 | -$231K | |
| 2 | -$47K | |
| 3 | -$32K | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$32K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$27K |